Ovoca Bio plc (ISE: OVXA)
Ireland
· Delayed Price · Currency is EUR 0.0100
0.00 (0.00%)
Jul 3, 2024, 9:00 PM GMT
Ovoca Bio Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Year Ending | TTM | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
| Selling, General & Admin | 1.87 | 1.87 | 5.42 | 6.1 | 2.21 | 2.32 | Upgrade
|
| Other Operating Expenses | -1.02 | -1.02 | -1.46 | -0.24 | - | - | Upgrade
|
| Operating Expenses | 0.85 | 0.85 | 3.97 | 5.86 | 2.21 | 2.32 | Upgrade
|
| Operating Income | -0.85 | -0.85 | -3.97 | -5.86 | -2.21 | -2.32 | Upgrade
|
| Interest Expense | -0.01 | -0.01 | -0.04 | -0.02 | -0.02 | -0.02 | Upgrade
|
| Interest & Investment Income | - | - | 0 | 0.1 | 0.23 | 0.4 | Upgrade
|
| Net Interest Expenses | -0.01 | -0.01 | -0.04 | 0.08 | 0.22 | 0.38 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.05 | 0.05 | -1.28 | 0.53 | -0.33 | 0.03 | Upgrade
|
| EBT Excluding Unusual Items | -0.81 | -0.81 | -5.28 | -5.25 | -2.32 | -1.9 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | -0.31 | - | 0 | 0 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -0.02 | - | - | - | Upgrade
|
| Asset Writedown | -4.3 | -4.3 | - | - | - | - | Upgrade
|
| Pretax Income | -5.1 | -5.1 | -5.61 | -5.25 | -2.32 | -1.9 | Upgrade
|
| Earnings From Continuing Operations | -5.1 | -5.1 | -5.61 | -5.25 | -2.32 | -1.9 | Upgrade
|
| Earnings From Discontinued Operations | 0.4 | 0.4 | - | -0.23 | -0.05 | -0.08 | Upgrade
|
| Net Income to Company | -4.7 | -4.7 | -5.61 | -5.48 | -2.37 | -1.98 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | 0.04 | 0.41 | Upgrade
|
| Net Income | -4.7 | -4.7 | -5.61 | -5.48 | -2.34 | -1.57 | Upgrade
|
| Net Income to Common | -4.7 | -4.7 | -5.61 | -5.48 | -2.34 | -1.57 | Upgrade
|
| Shares Outstanding (Basic) | 82 | 82 | 82 | 82 | 82 | 82 | Upgrade
|
| Shares Outstanding (Diluted) | 82 | 82 | 82 | 82 | 82 | 82 | Upgrade
|
| Shares Change (YoY) | 0.03% | - | - | - | - | - | Upgrade
|
| EPS (Basic) | -0.06 | -0.06 | -0.07 | -0.07 | -0.03 | -0.02 | Upgrade
|
| EPS (Diluted) | -0.06 | -0.06 | -0.07 | -0.07 | -0.03 | -0.02 | Upgrade
|
| Free Cash Flow | 1.12 | 1.12 | -5.16 | -4.39 | -2.12 | -2.17 | Upgrade
|
| Free Cash Flow Per Share | 0.01 | 0.01 | -0.06 | -0.05 | -0.03 | -0.03 | Upgrade
|
| EBITDA | -0.55 | -0.55 | -3.44 | -5.78 | -2.13 | -2.24 | Upgrade
|
| D&A For EBITDA | 0.3 | 0.3 | 0.53 | 0.08 | 0.07 | 0.07 | Upgrade
|
| EBIT | -0.85 | -0.85 | -3.97 | -5.86 | -2.21 | -2.32 | Upgrade
|
Source: S&P Capital IQ. Standard template.